Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
==========================================================================================================================================================================================================

* Hyun Cheol Chung
* Hendrik-Tobias Arkenau
* Jeeyun Lee
* Sun Young Rha
* Do-Youn Oh
* Lucjan Wyrwicz
* Yoon-Koo Kang
* Keun-Wook Lee
* Jeffrey R. Infante
* Sung Sook Lee
* Margaret Kemeny
* Ulrich Keilholz
* Bohuslav Melichar
* Alain Mita
* Ruth Plummer
* Denis Smith
* Arnold B. Gelb
* Huiling Xiong
* Janet Hong
* Vikram Chand
* Howard Safran